Deep learning boosts sensitivity of mass spectrometry-based immunopeptidomics
Mathias Wilhelm,Daniel P Zolg,Michael Graber,Siegfried Gessulat,Tobias Schmidt,Karsten Schnatbaum,Celina Schwencke-Westphal,Philipp Seifert,Niklas de Andrade Krätzig,Johannes Zerweck,Tobias Knaute,Eva Bräunlein,Patroklos Samaras,Ludwig Lautenbacher,Susan Klaeger,Holger Wenschuh,Roland Rad,Bernard Delanghe,Andreas Huhmer,Steven A Carr,Karl R Clauser,Angela M Krackhardt,Ulf Reimer,Bernhard Kuster
DOI: https://doi.org/10.1038/s41467-021-23713-9
2021-06-07
Abstract:Characterizing the human leukocyte antigen (HLA) bound ligandome by mass spectrometry (MS) holds great promise for developing vaccines and drugs for immune-oncology. Still, the identification of non-tryptic peptides presents substantial computational challenges. To address these, we synthesized and analyzed >300,000 peptides by multi-modal LC-MS/MS within the ProteomeTools project representing HLA class I & II ligands and products of the proteases AspN and LysN. The resulting data enabled training of a single model using the deep learning framework Prosit, allowing the accurate prediction of fragment ion spectra for tryptic and non-tryptic peptides. Applying Prosit demonstrates that the identification of HLA peptides can be improved up to 7-fold, that 87% of the proposed proteasomally spliced HLA peptides may be incorrect and that dozens of additional immunogenic neo-epitopes can be identified from patient tumors in published data. Together, the provided peptides, spectra and computational tools substantially expand the analytical depth of immunopeptidomics workflows.